CME Group (CME)
(Delayed Data from NSDQ)
$261.53 USD
+0.94 (0.36%)
Updated Sep 19, 2025 03:59 PM ET
After-Market: $259.50 -2.03 (-0.78%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth C Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CME 261.53 +0.94(0.36%)
Will CME be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CME based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CME
Intercontinental Exchange Trades Above 200-Day SMA: Time to Hold?
NDAQ Outperforms Industry, Trades Near 52-Week High: Time to Buy?
CME: What are Zacks experts saying now?
Zacks Private Portfolio Services
CME Group Trades Above 200-Day SMA: Time to Hold CME Stock?
CBOE Stock Rises 26.1% YTD: A Signal for Investors to Hold Tight?
CME (CME) Down 1.4% Since Last Earnings Report: Can It Rebound?
Other News for CME
CME to Introduce Options on Solana and XRP Futures
Crypto Currents: Bullish secures New York BitLicense from NYDFS
Crypto Currents: Bullish secures New York BitLicense from NYDFS
CME forms MACD Bullish Signal Line Cross on September 18
Dividend Champion, Contender, And Challenger Highlights: Week Of September 21